Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell LymphomaElise A. Olsen, Jean Nichols, Eric C. Vonderheid et al.|Journal of Clinical Oncology|2001Cited by 610
The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2Weiguo Liu, Allan R. Oseroff, Maria R. Baer et al.|Clinical Cancer Research|2007Cited by 137